Recall one batch of DACAROL 200 mg injection
2024-02-28
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer DACAROL 200 mg injection DACARBAZINE غير مسجل X2LI012B Venus Remedies, India
<p><span><span>Saudi FDA issued Recall one batch (X2LI012B) of DACAROL 200 mg injection due to change in product color. Laboratory tests indicated that the product does not meet accepted specifications. </span></span></p>
<p><span><span><strong><span>For healthcare professionals: </span></strong></span></span></p>
<ul>
<li><span><span><span>Stop dispensing the above batch immediately. Embargo/Quarantine all remaining stock. Affected batch should be returned to the supplier.</span></span></span></li>
<li><span><span><span>Contact the recalling firm or SFDA if you have any questions about the recall.</span></span></span></li>
<li><span><span><span>Adverse reactions or quality problems experienced with the use of this product may be reported to </span><a href="https://ade.sfda.gov.sa/"><span>Saudi Vigilance</span></a><span> either online or call center (Call 19999).</span></span></span></li>
</ul>
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.